Targeted protein degradation promises to lead the way to effective drugs for challenging targets

May 7, 2021

Researchers are using targeted protein degradation as a strategy to develop drugs that target disease-causing proteins where traditional inhibitor drugs can’t be used. 

In this infographic, we discuss both inhibition and degradation, the advantages and challenges related to each approach, and the key points you need to consider when designing your protein degraders. 

 

Learn how researchers are using NanoTemper tools to evaluate the affinity and specificity of their PROTAC candidate. 

Previous Article
10 terms to help you more easily understand targeted protein degradation
10 terms to help you more easily understand targeted protein degradation

Targeted Protein Degradation (TPD), a relatively new therapeutic approach, is making waves by targeting oth...

Up next
High-throughput determination of protein affinities using unmodified peptide libraries in nanomolar scale
High-throughput determination of protein affinities using unmodified peptide libraries in nanomolar scale

Ready to tackle your challenging affinity screening?

Discover tools you can use

Learn more